Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||
| Cash from operating activities | -56.18%152.42K | 133.13%347.83K | 149.2K | -323.70%-901.02K | 1,666.56%402.78K | 22.8K |
| Net profit before non-cash adjustment | 77.34%-1.42M | 66.14%-6.28M | ---18.56M | -57.34%1.3M | -11.63%3.06M | --3.46M |
| Total adjustment of non-cash items | -81.29%414.32K | -83.24%2.21M | --13.21M | 82.43%1.52M | -61.39%832.34K | --2.16M |
| -Depreciation and amortization | -71.05%298.94K | -39.80%1.03M | --1.72M | 48.05%740.48K | 15.36%500.17K | --433.57K |
| -Reversal of impairment losses recognized in profit and loss | -114.73%-48.89K | -96.84%331.95K | --10.51M | 56.78%290.14K | 96.85%185.06K | --94.01K |
| -Assets reserve and write-off | ---- | ---- | ---- | ---- | -164.32%-1.09M | --1.7M |
| -Disposal profit | -14.64%252.66K | 1,017.99%295.98K | --26.47K | --0 | --0 | --0 |
| -Net exchange gains and losses | -335.73%-363.26K | -134.51%-83.37K | --241.55K | 260.32%146.11K | -29.23%-91.14K | ---70.52K |
| -Other non-cash items | -56.85%274.88K | -11.48%637.03K | --719.6K | 43.42%341.69K | 14,624.66%238.25K | --1.62K |
| Changes in working capital | -73.69%1.16M | -19.66%4.42M | --5.5M | -6.77%-3.72M | 37.65%-3.49M | ---5.59M |
| -Change in receivables | 6.10%2.14M | -78.24%2.02M | --9.28M | -117.39%-7.74M | 60.91%-3.56M | ---9.11M |
| -Change in inventory | -54.84%558.16K | 456.70%1.24M | ---346.5K | -350.48%-534.78K | 441.08%213.5K | ---62.6K |
| -Change in payables | -232.57%-1.54M | 133.76%1.16M | ---3.44M | 3,376.27%4.56M | -103.88%-139.04K | --3.58M |
| Dividends paid (cash flow from operating activities) | ||||||
| Dividends received (cash flow from operating activities) | ||||||
| Interest paid (cash flow from operating activities) | 86.47%-50.38K | -5.82%-372.45K | -351.95K | -412.34%-131.62K | -794.50%-25.69K | -2.87K |
| Interest received (cash flow from operating activities) | 384 | 0 | 49.42K | 234.03%28.1K | 261.76%8.41K | 2.33K |
| Tax refund paid | 114.51%69.55K | 65.83%-479.35K | -1.4M | -187.05%-1.57M | -1,480.62%-548.43K | -34.7K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 134.12%171.97K | 67.62%-503.97K | ---1.56M | -1,482.77%-2.58M | -1,209.31%-162.93K | ---12.44K |
| Investing cash flow | ||||||
| Net PPE purchase and sale | 113.47%67.02K | 73.70%-497.66K | ---1.89M | -391.83%-767.66K | 32.60%-156.08K | ---231.59K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- |
| Investing cash flow | 113.47%67.02K | 73.70%-497.66K | ---1.89M | -391.83%-767.66K | 32.60%-156.08K | ---231.59K |
| Financing cash flow | ||||||
| Net issuance payments of debt | 95.26%-32.91K | -151.93%-694.34K | --1.34M | -144.34%-408.77K | 58.51%921.82K | --581.54K |
| Net common stock issuance | ---- | --0 | --4M | 623.95%6.52M | 200.04%900.12K | --300K |
| Increase or decrease of lease financing | 48.23%-305.84K | 41.00%-590.72K | ---1M | -75.38%-424.53K | 28.71%-242.06K | ---339.54K |
| Issuance fees | ---- | ---- | ---- | ---217.78K | --0 | ---- |
| Interest paid (cash flow from financing activities) | 72.73%-95.68K | 16.46%-350.83K | ---419.97K | -24.75%-275.66K | -41.78%-220.97K | ---155.85K |
| Net other fund-raising expenses | 254.05%72.91K | 95.24%-47.33K | ---994.35K | -467.82%-388.45K | 77.37%-68.41K | ---302.33K |
| Financing cash flow | 78.52%-361.52K | -157.61%-1.68M | --2.92M | 272.04%4.8M | 1,439.51%1.29M | --83.83K |
| Net cash flow | ||||||
| Beginning cash position | -126.51%-562.66K | -19.90%2.12M | --2.65M | 435.60%1.19M | -41.80%223.02K | --383.23K |
| Current changes in cash | 95.44%-122.53K | -409.35%-2.68M | ---527.11K | 49.75%1.45M | 706.39%971.5K | ---160.21K |
| End cash Position | -21.78%-685.18K | -126.51%-562.66K | --2.12M | 121.79%2.65M | 435.60%1.19M | --223.02K |
| Free cash flow | 115.07%171.97K | 69.62%-1.14M | ---3.75M | -949.01%-3.35M | 64.67%-319.01K | ---902.87K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.